OptiNose, Inc. NASDAQ:OPTN

OptiNose stock price today

$9.6
+9.20
+2347.11%
Financial Health
0
1
2
3
4
5
6
7
8
9

OptiNose stock price monthly change

-69.13%
month

OptiNose stock price quarterly change

-69.13%
quarter

OptiNose stock price yearly change

-71.18%
year

OptiNose key metrics

Market Cap
60.37M
Enterprise value
202.71M
P/E
-2.44
EV/Sales
2.65
EV/EBITDA
-3.52
Price/Sales
2.17
Price/Book
-2.92
PEG ratio
-0.06
EPS
-0.26
Revenue
74.02M
EBITDA
-16.24M
Income
-30.70M
Revenue Q/Q
25.61%
Revenue Y/Y
0.89%
Profit margin
-98.11%
Oper. margin
-73.28%
Gross margin
87.86%
EBIT margin
-73.28%
EBITDA margin
-21.95%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

OptiNose stock price history

OptiNose stock forecast

OptiNose financial statements

Average Price Target
Last Year

$1

Potential downside: -89.58%

Based on estimate of 1 analysts
  • Analysts Price target

  • Financials & Ratios estimates

OptiNose, Inc. (NASDAQ:OPTN): Profit margin
Jun 2023 19.45M 2.62M 13.5%
Sep 2023 19.82M -9.29M -46.88%
Dec 2023 19.86M -9.96M -50.17%
Mar 2024 14.88M -14.06M -94.54%
OptiNose, Inc. (NASDAQ:OPTN): Debt to assets
Jun 2023 106068000 175.72M 165.67%
Sep 2023 101407000 179.02M 176.54%
Dec 2023 107729000 194.33M 180.39%
Mar 2024 83707000 182.92M 218.53%
OptiNose, Inc. (NASDAQ:OPTN): Cash Flow
Jun 2023 -12.53M -79K -1K
Sep 2023 -4.42M -176K 135K
Dec 2023 6.90M -73K 4K
Mar 2024 -22.02M -22K 7K

OptiNose alternative data

OptiNose, Inc. (NASDAQ:OPTN): Employee count
Aug 2023 141
Sep 2023 141
Oct 2023 141
Nov 2023 141
Dec 2023 141
Jan 2024 141
Feb 2024 141
Mar 2024 132
Apr 2024 132
May 2024 132
Jun 2024 132
Jul 2024 132

OptiNose other data

57.93% +3.44%
of OPTN is owned by hedge funds
32.93M +3.87M
shares is hold by hedge funds

OptiNose, Inc. (NASDAQ:OPTN): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 52875
Mar 2024 0 36602
Jun 2024 0 25824
Jul 2024 0 167679
Sep 2024 0 8107
Dec 2024 0 7664
Transaction Date Insider Security Shares Price per share Total value Source
Sale
MARINO MICHAEL F III officer: Chief Le.. Common Stock 3,050 $0.44 $1,342
Sale
MAHMOUD RAMY A director, officer.. Common Stock 4,614 $0.44 $2,030
Sale
MARINO MICHAEL F III officer: Chief Le.. Common Stock 3,226 $0.87 $2,807
Sale
MAHMOUD RAMY A director, officer.. Common Stock 4,881 $0.87 $4,246
Sale
KRICK ANTHONY J officer: Chief Accounting Officer
Common Stock 6,845 $1.14 $7,803
Sale
MARINO MICHAEL F III officer: Chief Le.. Common Stock 49,408 $1.14 $56,325
Sale
MAHMOUD RAMY A director, officer.. Common Stock 111,426 $1.14 $127,026
Sale
MARINO MICHAEL F III officer: Chief Le.. Common Stock 3,267 $1.19 $3,888
Sale
MAHMOUD RAMY A director, officer.. Common Stock 18,987 $1.19 $22,595
Sale
KRICK ANTHONY J officer: Chief Accounting Officer
Common Stock 624 $1.19 $743
Thursday, 26 December 2024
globenewswire.com
Monday, 2 December 2024
globenewswire.com
Tuesday, 12 November 2024
seekingalpha.com
zacks.com
globenewswire.com
Tuesday, 5 November 2024
globenewswire.com
Wednesday, 16 October 2024
globenewswire.com
Monday, 7 October 2024
globenewswire.com
Thursday, 5 September 2024
globenewswire.com
Monday, 26 August 2024
globenewswire.com
Sunday, 11 August 2024
seekingalpha.com
Thursday, 8 August 2024
zacks.com
Friday, 2 August 2024
globenewswire.com
Tuesday, 2 July 2024
investorplace.com
Thursday, 27 June 2024
globenewswire.com
Friday, 17 May 2024
seekingalpha.com
globenewswire.com
Tuesday, 14 May 2024
Zacks Investment Research
Friday, 10 May 2024
GlobeNewsWire
Thursday, 4 April 2024
GlobeNewsWire
Thursday, 7 March 2024
Zacks Investment Research
Thursday, 29 February 2024
GlobeNewsWire
Tuesday, 24 October 2023
Zacks Investment Research
Friday, 22 September 2023
GlobeNewsWire
Thursday, 24 August 2023
Zacks Investment Research
Thursday, 10 August 2023
Zacks Investment Research
Tuesday, 1 August 2023
Seeking Alpha
Friday, 2 June 2023
GlobeNewsWire
Thursday, 11 May 2023
Seeking Alpha
Zacks Investment Research
  • What's the price of OptiNose stock today?

    One share of OptiNose stock can currently be purchased for approximately $9.6.

  • When is OptiNose's next earnings date?

    Unfortunately, OptiNose's (OPTN) next earnings date is currently unknown.

  • Does OptiNose pay dividends?

    No, OptiNose does not pay dividends.

  • How much money does OptiNose make?

    OptiNose has a market capitalization of 60.37M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 6.93% to 70.99M US dollars.

  • What is OptiNose's stock symbol?

    OptiNose, Inc. is traded on the NASDAQ under the ticker symbol "OPTN".

  • What is OptiNose's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of OptiNose?

    Shares of OptiNose can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are OptiNose's key executives?

    OptiNose's management team includes the following people:

    • Mr. Peter K. Miller Chief Executive Officer & Director(age: 64, pay: $999,810)
    • Dr. Ramy A. Mahmoud M.D., M.P.H. Pres & Chief Operating Officer(age: 60, pay: $737,550)
    • Mr. Michael F. Marino Chief Legal Officer & Corporation Sec.(age: 49, pay: $604,710)
    • Mr. Keith Alan Goldan Chief Financial Officer(age: 54, pay: $600,210)
    • Mr. Victor M. Clavelli Chief Commercial Officer(age: 52, pay: $584,200)
  • How many employees does OptiNose have?

    As Jul 2024, OptiNose employs 132 workers.

  • When OptiNose went public?

    OptiNose, Inc. is publicly traded company for more then 7 years since IPO on 13 Oct 2017.

  • What is OptiNose's official website?

    The official website for OptiNose is optinose.com.

  • Where are OptiNose's headquarters?

    OptiNose is headquartered at 1020 Stony Hill Road, Yardley, PA.

  • How can i contact OptiNose?

    OptiNose's mailing address is 1020 Stony Hill Road, Yardley, PA and company can be reached via phone at +267 364 3500.

  • What is OptiNose stock forecast & price target?

    Based on 1 Wall Street analysts` predicted price targets for OptiNose in the last 12 months, the avarage price target is $1. The average price target represents a -89.58% change from the last price of $9.6.

OptiNose company profile:

OptiNose, Inc.

optinose.com
Exchange:

NASDAQ

Full time employees:

132

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.

1020 Stony Hill Road
Yardley, PA 19067

CIK: 0001494650
ISIN: US68404V1008
CUSIP: 68404V100